Abstract
Introduction

Amyloidosis is a systemic or local disease in which amyloid substances are deposited extracellularly and impair tissue function. Amyloid substances are derived from a variety of peptides, such as amyloid light chain (AL), immunoglobulins, transthyretin, β2 microglobulin, amyloid Aβ, calcitonin, and islet amyloid polypeptides (amylin)
. Although the mechanism by which amyloid fibrils are elaborated has extensively been explored, its precise process is still poorly understood (3) .
It has been shown that local amyloid deposition very infrequently takes place at the site of repeated insulin injection in patients with insulin requiring diabetes (4, 5) . The amyloid at the injected site was identified as amyloid insulin type (A-Ins) (1, 2) . To date, there are only 3 case reports in the English language literature on localized amyloidosis caused by repeated insulin injection in diabetic patients (4, 6) . The nature of amyloid in the insulin injection site is considered to be insulin itself (4, 5) or insulin-related substance (6) i n a n d u s e o f i n s u l i n i n t h e p a t i e n t . (Fig. 3A) . There were a mo r p h o u s ma t e r i a l s ( A) . T h e r e a r e a r e a s mi x e d wi t h i n f i l t r a t i o n o f l y mp h o c y t e s , ma c r o p h a g e s  a n d f o r e i g n b o d y g i a n t c e l l s , i n d i c a t i n g i n f l a mma t o r y r e a c t i o n s a g a i n s t f o r e i g n a n t i g e n s ( B ) . ( Or i g i n a l ma g n i f i c a t i o n ; A, × 1 2 0 . B , × 3 6 0 (Fig. 3B) . (Fig. 4A) , but incompletely digested with potassium permanganate. They yielded green-birefringence on polarized microscopy even after digestion (Fig. 4B) T a b l e 1 . S u mma r y o f P r e v i o u s Ca s e s wi t h L o c a l i z e d Amy l o i d o s i s a t t h e S i t e o f I n s u l i n I n j e c t i o n (4, 6) . One of the previous cases was insulin resistant with elevated HbA1c levels as in our case (6) 
F i g u r e 2 . CT i ma g e o f a s u b c u t a n e o u s ma s s i n t h e p a t i e n t ( a r r o ws
F i g u r e 3 . L i g h t mi c r o s c o p i c f i n d i n g s o f t h e a b d o mi n a l ma s s s h o wi n g d e p o s i t i o n o f e o s i n o p h i l i c
F i g u r e 4 . Co n f i r ma t i o n o f a my l o i d a s A-I n s t y p e b y s p e c i f i c s t a i n i n g . T h e h o mo g e n o u s d e p o s it i o n s a r e u n i f o r ml y p o s i t i v e wi t h Co n g o -r e d ( A) , s h o wi n g g r e e n b i r e f r i n g e n c e a f t e r p o t a s s i u m p e rma n g a n a t e d i g e s t i o n b y p o l a r i z e d mi c r o s c o p y ( B ) . I mmu n o s t a i n s wi t h i n s u l i n s h o w p o s i t i v e r e a ct i o n s ( C) . ( o r i g i n a l ma g n i f i c a t i o n × 2 8 0 f o r a l l ) scattered foci of growth of small blood vessels, infiltration of lymphoid cells, plasma cells and macrophages
From place to place, foreign body giant cells surrounded the white transparent amorphous deposits. The eosinophilic homogenous materials were positive with Congo-red stains
Discussion
More than 20 amyloid proteins and 24 precursor proteins are now identified to attribute to formation of amyloid fibrils through common pathways (1, 2). In patients with diabetes, except for pancreatic islets, localized amyloid deposition is unusual and known to occur only at the site of insulin injection. A survey of the English language literature dis-
closed only 3 cases of localized insulin-induced amyloidosis (Table 1) (4, 6). Localized amyloid at the site of insulin injection is now termed as iatrogenic endocrine amyloidosis composed of A-Ins type amyloid of which the precursor is insulin peptide (1, 2). In previous cases, amyloid formation was suspected to be correlated with non-human insulin products, in particular those of porcine origin (4, 5). However, in the present case, the use was limited to only human recombinant insulin or human insulin semisynthetic analogue, and therefore the species of insulin does not seem to be a major reason for the amyloidogenesis in insulin in
